Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-062241

Chief Executive Officer acquired 252,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2022-12-16 Grant or award +18,375 3,486,689 D: show line 1 in the form
Anzalone Christopher Richard Chief Executive Officer 2022-12-20 Grant or award +234,025 3,720,714 D: show line 2 in the form
Loading xslF345X03/doc4.xml…